Zanardi R

Department of Clinical Neurosciences, San Raffaele Vita-Salute University.

8 papers · ORCID

ArticleKetamine

Higher Neutrophil-to-Lymphocyte Ratio Is Associated With Better Response to Esketamine in Treatment-Resistant Depression: A Post Hoc Exploratory Analysis of Real-World Data.

Carminati M, Tondello M, Morana C +2

Europe PMC2026
ArticleKetamine

Intravenous Ketamine Followed by Intranasal Esketamine in 2 Subsequent Treatment-resistant Depressive Episodes: Insights From a Case Series.

Carminati M, Tondello M, Barbini B +1

Europe PMC2025
ArticleKetamine

Effectiveness of repeated Esketamine nasal spray administration on anhedonic symptoms in treatment-resistant bipolar and unipolar depression: A secondary analysis from the REAL-ESK study group.

d'Andrea G, Cavallotto C, Pettorruso M +25

Europe PMC2025
ArticleKetamine

Patient Experience with Intranasal Esketamine in Treatment-Resistant Depression: Insights from a Multicentric Italian Study (REAL-ESKperience).

Di Nicola M, Pepe M, d'Andrea G +26

Europe PMC2025
ArticleKetamine

The rapid antidepressant effectiveness of repeated dose of intravenous ketamine and intranasal esketamine: A post-hoc analysis of pooled real-world data.

d'Andrea G, Pettorruso M, Di Lorenzo G +16

Europe PMC2024
ArticleKetamine

Predicting outcome with Intranasal Esketamine treatment: A machine-learning, three-month study in Treatment-Resistant Depression (ESK-LEARNING).

Pettorruso M, Guidotti R, d'Andrea G +25

Europe PMC2023
ArticleKetamine

Investigating the Effectiveness and Tolerability of Intranasal Esketamine Among Older Adults With Treatment-Resistant Depression (TRD): A Post-hoc Analysis from the REAL-ESK Study Group.

d'Andrea G, Chiappini S, McIntyre RS +12

Europe PMC2023
ArticleKetamine

Treating bipolar depression with esketamine: Safety and effectiveness data from a naturalistic multicentric study on esketamine in bipolar versus unipolar treatment-resistant depression.

Martinotti G, Dell'Osso B, Di Lorenzo G +23

Europe PMC2023